DoW Breast Cancer, Clinical Research Extension Award

Dept. of the Army -- USAMRAA

Published: May 4, 2026

Updated: Jun 18, 2026

Source: grants_gov

About This Opportunity

Dept (United States) seeks grant funding — DoW Breast Cancer, Clinical Research Extension Award. healthcare. Submission deadline Jul 2026.

This is a grants contract in the health and medical services and Research sectors. Located in United States, North America, this opportunity is open to firms and consortiums. Proposals must be submitted before July 8, 2026.

Published through Grants.gov, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for grants in the health and medical services sector. Grant applications generally require a detailed project proposal, a clear results framework, and evidence of the applicant's capacity to deliver the proposed activities. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception . Distinctive Features: · The research team must include two or more breast cancer consumer advocates. · This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Agency: Jamie Shortall
Grant Officer

CFDA: 12.420

Applicant Types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Cost Sharing: No

Contact: Jamie Shortall
Grant Officer

Email: help@eBRAP.org

Data provenance

This notice is sourced from Grants.gov and was originally published on May 4, 2026. Last refreshed 6 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Dept. of the Army -- USAMRAA

Dept. of the Army -- USAMRAA has issued 77 procurement notices on BidsFactory, including 77 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, Research & Innovation, and Information & Communication Technology. All notices are published for United States. Notices are distributed via Grants.gov. Most recent publication: June 17, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Grants contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in United States. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Grants.gov to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is July 8, 2026. You have 14 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by Dept. of the Army -- USAMRAA in United States. The authority is responsible for evaluating bids, awarding the contract, and managing performance.